Perspective Therapeutics (CATX) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $116.3 million.
- Perspective Therapeutics' Non-Current Assets fell 384.85% to $116.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $454.6 million, marking a year-over-year increase of 1845.66%. This contributed to the annual value of $109.9 million for FY2024, which is 3563.92% up from last year.
- Per Perspective Therapeutics' latest filing, its Non-Current Assets stood at $116.3 million for Q3 2025, which was down 384.85% from $114.8 million recorded in Q2 2025.
- Perspective Therapeutics' Non-Current Assets' 5-year high stood at $121.0 million during Q3 2024, with a 5-year trough of $3.1 million in Q2 2021.
- In the last 5 years, Perspective Therapeutics' Non-Current Assets had a median value of $87.4 million in 2023 and averaged $59.7 million.
- In the last 5 years, Perspective Therapeutics' Non-Current Assets soared by 250444.11% in 2023 and then plummeted by 384.85% in 2025.
- Perspective Therapeutics' Non-Current Assets (Quarter) stood at $3.6 million in 2021, then surged by 33.66% to $4.9 million in 2022, then skyrocketed by 1562.31% to $81.1 million in 2023, then skyrocketed by 35.64% to $109.9 million in 2024, then increased by 5.81% to $116.3 million in 2025.
- Its Non-Current Assets was $116.3 million in Q3 2025, compared to $114.8 million in Q2 2025 and $113.6 million in Q1 2025.